DE69522701D1 - Selegilin enthaltende liposomale mittel - Google Patents

Selegilin enthaltende liposomale mittel

Info

Publication number
DE69522701D1
DE69522701D1 DE69522701T DE69522701T DE69522701D1 DE 69522701 D1 DE69522701 D1 DE 69522701D1 DE 69522701 T DE69522701 T DE 69522701T DE 69522701 T DE69522701 T DE 69522701T DE 69522701 D1 DE69522701 D1 DE 69522701D1
Authority
DE
Germany
Prior art keywords
weight
pct
liposomic
composition
selegilin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69522701T
Other languages
English (en)
Other versions
DE69522701T2 (de
Inventor
Michael Mezei
J Zsef Gaal
Gabor Szekacs
Gyula Szebeni
Tamasne Marmarosi
Kalman Magyar
Jetazsef Lengyel
Istvan Szatmari
Gnes Turi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Application granted granted Critical
Publication of DE69522701D1 publication Critical patent/DE69522701D1/de
Publication of DE69522701T2 publication Critical patent/DE69522701T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Detergent Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69522701T 1994-10-24 1995-10-20 Selegilin enthaltende liposomale mittel Expired - Fee Related DE69522701T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9403073A HU223475B1 (hu) 1994-10-24 1994-10-24 Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására
PCT/HU1995/000052 WO1996012472A1 (en) 1994-10-24 1995-10-20 Liposome composition containing selegilin

Publications (2)

Publication Number Publication Date
DE69522701D1 true DE69522701D1 (de) 2001-10-18
DE69522701T2 DE69522701T2 (de) 2002-07-11

Family

ID=10985697

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69522701T Expired - Fee Related DE69522701T2 (de) 1994-10-24 1995-10-20 Selegilin enthaltende liposomale mittel

Country Status (30)

Country Link
US (1) US5888536A (de)
EP (1) EP0788349B1 (de)
JP (1) JPH10507749A (de)
KR (1) KR100313149B1 (de)
CN (1) CN1084186C (de)
AT (1) ATE205387T1 (de)
AU (1) AU691348B2 (de)
BG (1) BG63327B1 (de)
BR (1) BR9509517A (de)
CA (1) CA2203513C (de)
CZ (1) CZ287349B6 (de)
DE (1) DE69522701T2 (de)
DK (1) DK0788349T3 (de)
EE (1) EE03418B1 (de)
ES (1) ES2160718T3 (de)
FI (1) FI971743A0 (de)
HU (1) HU223475B1 (de)
IL (1) IL115754A (de)
NO (1) NO316354B1 (de)
NZ (1) NZ294660A (de)
PL (1) PL183104B1 (de)
PT (1) PT788349E (de)
RO (1) RO116768B1 (de)
RU (1) RU2159106C2 (de)
SK (1) SK281599B6 (de)
TW (1) TW412420B (de)
UA (1) UA44289C2 (de)
WO (1) WO1996012472A1 (de)
YU (1) YU49313B (de)
ZA (1) ZA958999B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1052983A2 (de) * 1998-01-27 2000-11-22 Thomas N. Thomas Verwendung eines mao-a oder mao-b inhibitors zur behandlung der gefässerkrankungen
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
CA2536393A1 (en) * 2003-09-09 2005-06-16 Gilead Sciences, Inc. Use of liposomes which are small unilamellar vesicles for the removal of an entity from a biological sample
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
CN1813679A (zh) * 2005-11-30 2006-08-09 上海医药(集团)有限公司 一种紫杉烷脂质体冻干组合物及其制备方法
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5623102B2 (ja) * 2010-03-12 2014-11-12 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
JP5693026B2 (ja) * 2010-03-12 2015-04-01 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
WO2013168167A1 (en) * 2012-05-10 2013-11-14 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
AU2015326378B2 (en) * 2014-09-29 2021-01-21 Council Of Scientific & Industrial Research A formulation useful for delivery of neuro protecting agent
LT3600435T (lt) * 2017-03-23 2024-04-25 Lipid Systems Sp. Z.O.O. Hidrofilinių junginių aukšto efektyvumo įkapsuliavimas vienasluoksnėse liposomose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (de) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.

Also Published As

Publication number Publication date
IL115754A0 (en) 1996-01-19
IL115754A (en) 1999-07-14
NO971870L (no) 1997-06-24
NZ294660A (en) 1998-05-27
DE69522701T2 (de) 2002-07-11
US5888536A (en) 1999-03-30
FI971743A (fi) 1997-04-23
CA2203513C (en) 2001-10-09
EP0788349B1 (de) 2001-09-12
WO1996012472A1 (en) 1996-05-02
TW412420B (en) 2000-11-21
RO116768B1 (ro) 2001-06-29
EE03418B1 (et) 2001-06-15
ZA958999B (en) 1996-05-15
KR100313149B1 (ko) 2002-02-19
HUT76053A (en) 1997-06-30
YU49313B (sh) 2005-06-10
NO316354B1 (no) 2004-01-19
CA2203513A1 (en) 1996-05-02
PL183104B1 (pl) 2002-05-31
UA44289C2 (uk) 2002-02-15
FI971743A0 (fi) 1997-04-23
ES2160718T3 (es) 2001-11-16
CZ114797A3 (en) 1997-10-15
HU9403073D0 (en) 1994-12-28
CN1084186C (zh) 2002-05-08
KR970706797A (ko) 1997-12-01
RU2159106C2 (ru) 2000-11-20
SK281599B6 (sk) 2001-05-10
ATE205387T1 (de) 2001-09-15
MX9703019A (es) 1997-10-31
AU3751895A (en) 1996-05-15
AU691348B2 (en) 1998-05-14
NO971870D0 (no) 1997-04-23
EP0788349A1 (de) 1997-08-13
BG101432A (en) 1997-12-30
YU67195A (sh) 1998-07-10
SK51797A3 (en) 1997-11-05
HU223475B1 (hu) 2004-07-28
CN1163563A (zh) 1997-10-29
BG63327B1 (bg) 2001-10-31
CZ287349B6 (en) 2000-10-11
PL319875A1 (en) 1997-09-01
BR9509517A (pt) 1997-12-30
EE9700102A (et) 1997-10-15
PT788349E (pt) 2001-12-28
DK0788349T3 (da) 2001-11-26
JPH10507749A (ja) 1998-07-28

Similar Documents

Publication Publication Date Title
ES2301189T3 (es) Agentes de limpieza antimicrobianos.
NO974023D0 (no) Topisk appliserbart farmasöytisk preparat, fremgangsmåte for dets fremstilling og anvendelse derav
DE69522701T2 (de) Selegilin enthaltende liposomale mittel
JP2011116690A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
JP5616589B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP5681472B2 (ja) 眼科用組成物
JP4801300B2 (ja) 外用液状組成物
JP2011111441A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2005075735A (ja) オキシメタゾリン含有組成物
JP2002338476A (ja) 腎透析に伴う痒みの予防治療剤
EP1539084B1 (de) Verfahren zur behandlung von weichen nägeln
JP2002104971A (ja) 眼科用組成物
JP2001187741A (ja) 皮膚外用医薬組成物
JPH11180872A (ja) 骨代謝改善剤
JPH1129461A (ja) ヒドロキシアスパラギン酸を含有する皮膚外用剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee